Stanford Department of Medicine Ranks Eighth in New NIH Research Rankings
Stanford Department of Medicine ranked eighth among departments of medicine nationwide in total National Institutes of Health (NIH) research funding for fiscal year 2022. The department received $172.6 million in total awards.
“Rankings don’t tell the whole story of research at the Department of Medicine, but this news is one validation of the department’s research excellence," said department chair Bob Harrington, MD. “I am very proud of our faculty, staff, and trainees for all the work they do to create an environment that supports this level of research.”
Jeffrey Glenn, MD, PhD, contributed significantly to the department’s portfolio with $69.83 million in funding, including funding he received to start an antiviral drug discovery center at Stanford. Glenn, a professor of hepatology and gastroenterology and of microbiology and immunology, received the second-highest funding among principal investigators from departments of medicine and internal medicine nationwide.
Harrington also credited the department’s NIH funding success to its evolving team science approach, reflecting the way contemporary science is conducted and funded.
Stanford School of Medicine was ranked second among schools of medicine, with over $584.07 million in funding. The Department of Medicine comprised 30% of the School of Medicine’s total NIH funding portfolio.
“I’m looking forward to even more research success, discoveries, implementation, and mentoring over the next few years,” Harrington said.